For Dr. John Murkin
, the medical device business is all about "making a better mouse trap."
The Schulich School of Medicine
& Dentistry professor is part of a team of Western and Lawson Health Research Institute (LHRI) researchers studying a new technology that may change the way patients undergoing cardiac surgery are monitored and managed in the hospital.
The device, known as CerOx, non-invasively monitors cerebral blood flow and helps physicians and nurses assess brain perfusion in real time.
, who has been involved in the machine's development, said this information could be used to support critical treatment decisions made to protect the patient from potential complications.
Schulich School of Medicine & Dentistry professor Dr. John Murkin shows off a research-based CerOx device, used to monitor oxygen saturation in and blood flow to the brain.
Photo credit: Paul Mayne//Western News
"We use near-infrared light routinely in all hospitals to measure oxygen saturation in the brain.
That's been out for 30 years," Murkin
An anesthetist at London Health Sciences Centre and a researcher at LHRI, Murkin has studied cognitive and neurological outcomes in cardiac surgery for more than three decades.
said there has been an unmet clinical need for a noninvasive tool that provides accurate, real-time measurements of cerebral blood flow in these highly vulnerable patients.
CerOx was developed by U.S.- and Israel-based Ornim Medical
, of which Murkin
is a member of their scientific advisory board.